title: [Chronic hepatitis C virus infection].
abstract: The only way to prevent the late sequelae of chronic HCV infection--liver cirrhosis or HCC--is by early and specific antiviral therapy. A prerequisite is the identification of HCV-infected persons in the general population. To accomplish this a screening concept that includes all patients with exposure risks or elevated serum transaminases is needed.
authors.affiliation: I. Medizinische Klinik, Krankenhaus Nordwest, Frankfurt am Main. siegbert.rossol@khnw.de
authors.forename: S
authors.initials: S
authors.lastname: Rossol
authors.forename: J
authors.initials: J
authors.lastname: Bartel
mesh_terms: D000410:Alanine Transaminase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood*; D003430:Cross-Sectional Studies; D003663:Decision Trees; D003937:Diagnosis, Differential; D005858:Germany; D019694:Hepatitis B, Chronic / Q000175:diagnosis* / Q000453:epidemiology; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D008111:Liver Function Tests; D011379:Prognosis
chemical_list: D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase